S&P ASX All Technology

US Dollar vs AUD

Register for streaming realtime charts, analysis tools, and prices.

Get Started

ADIL Adial Pharmaceuticals Inc

1.83

-0.07 (-3.68%)

Pre Market

Last Updated: 18:40:37

Delayed by 15 minutes

Adial Pharma secures new U.S. patent for AD04 for treatment of opioid use disorder

To read the full story on Seeking Alpha, click here.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals Inc News

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Monday 22 April 2024 (20 hours ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Wednesday 10 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Tuesday 2 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Saturday 2 March 2024 (2 months ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Wednesday 14 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 26 January 2024 (3 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Friday 19 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

More Adial Pharmaceuticals Inc News Articles

JP Morgan Chase

Gold vs US Dollar

Australian SE All Ordina...

Newcrest Mining

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions